Đorđe Kralj

9PUBLICATIONS
20CO-AUTHORS
AutoimmunityCardiovascular medicine and haematology not elsewhere classifiedImmunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Epidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 28, 2026
Unlocking the Potential of Population Pharmacokinetic Models of Adalimumab in Patients with Crohn's Disease.

|Jun 09, 2026
Irritable Bowel Syndrome Prevalence in Patients with Inflammatory Bowel Disease in Remission: Single-Center Experience.

|Mar 28, 2026
Arterial Thrombosis in Severe Ulcerative Colitis: A Case-Based Narrative Review of Current Evidence.

Djordje Kralj, Mladen Maksic, Tamara Knezevic Ivanovski

|Aug 28, 2025
Real-World Safety of Vedolizumab in Inflammatory Bowel Disease: A Retrospective Cohort Study Supported by FAERS Signal Analysis.

Bojana Milašinović, Sandra Vezmar Kovačević, Srđan Marković

|Aug 28, 2025
Is Deep Remission the Right Time to De-Escalate Biologic Therapy in IBD? A Single-Center Retrospective Study.

Tamara Knezevic Ivanovski, Marija Milic Perovic, Bojan Stopic

|Aug 14, 2025
Molecular Insight into the Role of HLA Genotypes in Immunogenicity and Secondary Refractoriness to Anti-TNF Therapy in IBD Patients.

Mladen Maksic, Irfan Corovic, Tijana Maksic

Pageof 2

Frequent Collaborators

7 joint publications

Petar Svorcan

4 joint publications

Katarina Vučićević

4 joint publications

Srdjan Markovic

2 joint publications

Mladen Maksic